Streetbeat News

Stock Prices

INSP

Inspire Medical Systems reported its Q3 financial results, which led to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:23 pm

AKAM

Akamai Technologies reported better-than-expected Q3 financial results and issued guidance, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:22 pm

STKS

The One Group Hospitality (NASDAQ:STKS) reported Q3 losses of $(0.08) per share, missing the analyst consensus estimate of $0.03 by 366.67%. This is a 214.29% decrease from the same period last year. The company also reported quarterly sales of $76.88 million, missing the analyst consensus estimate of $83.27 million by 7.67%. However, this is a 5.29% increase from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

November 07, 2023 | 9:22 pm

KVYO

Klaviyo (NYSE:KVYO) reported Q3 losses of $(1.24) per share, missing the analyst consensus estimate of $0.05 by 2580 percent. This is a 1140 percent decrease from the same period last year. However, the company's quarterly sales of $175.81 million beat the analyst consensus estimate of $167.06 million by 5.24 percent, marking a 47.53 percent increase from last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:21 pm

EBAY

eBay's shares are trading lower following the release of the company's Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:19 pm

CRSR

Corsair Gaming Inc. has updated its FY23 revenue forecast to $1.4B-$1.5B, compared to the previous range of $1.35B-$1.55B. Adjusted operating income is expected to be $80M-$90M, compared to the previous $75M-$95M. Adjusted EBITDA is expected to be $95M-$105M, compared to the previous $90M-$110M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:17 pm

CPNG

Coupang's shares are trading lower following the release of its Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:16 pm

VTRS

Viatris (NASDAQ:VTRS) reported Q3 sales of $3.94 billion, missing the analyst consensus estimate of $4.02 billion by 1.99 percent. This represents a 3.38 percent decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:16 pm

ICUI

ICU Medical, Inc. (NASDAQ:ICUI) reported mixed Q3 results, with earnings per share beating analyst estimates but sales falling short. The company's shares fell by 17.3% on Tuesday due to the results, with trading volume significantly higher than average.

Portfolio Pulse from Ryan Gustafson

November 07, 2023 | 9:15 pm

BMRN

IBB

Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc (BMRN), engaging with the company on its strategic direction amid leadership changes and the evolving status of its hemophilia treatment, Roctavian. The hedge fund has invested over $1 billion in BioMarin. Amidst these developments, BioMarin's stock has experienced a notable decline, dropping 24% year-to-date. This has triggered conversations about BioMarin's potential as an acquisition target.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 9:13 pm